HomeDiabetes ResearchMetabolomics Identifies a Biomarker Revealing In Vivo Loss of Functional β-Cell Mass Before Diabetes Onset Metabolomics Identifies a Biomarker Revealing In Vivo Loss of Functional β-Cell Mass Before Diabetes Onset Tweet Pin It Related Posts A New FGF21 Analog for the Treatment of Fatty Liver Disease Diabetes incidence plateaus at 8.2% of American adults Can adding liraglutide to insulin treatment improve eating behaviors for patients with type 1 diabetes?
Can adding liraglutide to insulin treatment improve eating behaviors for patients with type 1 diabetes?
